During the past decade, Hopital Emile Muller;Pneumologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Emile Muller;Pneumologie" are "Non-Squamous Non-Small Cell Lung Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Hepatocellular Carcinoma" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Hopital Emile Muller;Pneumologie" in a lesser frequency.

Most popular intervention types in "Hopital Emile Muller;Pneumologie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Alectinib" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Emile Muller;Pneumologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Emile Muller;Pneumologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hopital Emile Muller;Pneumologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Emile Muller;Pneumologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".